BioCryst Pharmaceuticals Inc (BCRX) — Financial Flexibility Index
BioCryst Pharmaceuticals Inc (BCRX) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-61.73 Million (operating CF $-62.14 Million minus capex $403.00K) represents 0% of total liabilities ($1.02 Billion). Also explore how fast is BioCryst Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioCryst Pharmaceuticals Inc Financial Flexibility Index (1994–2025)
Historical Financial Flexibility Index trend for BioCryst Pharmaceuticals Inc across 32 annual periods. Check BioCryst Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BioCryst Pharmaceuticals Inc (1994–2025)
Year-by-year free cash flow to debt coverage for BioCryst Pharmaceuticals Inc. For the full company profile including market capitalisation, see BCRX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.52x | $332.35 Million | $329.88 Million | $633.31 Million | ▲ +1096.4% |
| 2024 | -0.05x | $-50.90 Million | $-52.02 Million | $966.35 Million | ▲ +44.9% |
| 2023 | -0.10x | $-92.97 Million | $-95.14 Million | $972.49 Million | ▲ +49.7% |
| 2022 | -0.19x | $-160.50 Million | $-161.85 Million | $844.60 Million | ▲ +5.5% |
| 2021 | -0.20x | $-139.77 Million | $-142.16 Million | $695.14 Million | ▲ +47.9% |
| 2020 | -0.39x | $-136.70 Million | $-137.22 Million | $353.98 Million | ▲ +40.7% |
| 2019 | -0.65x | $-89.24 Million | $-89.58 Million | $137.03 Million | ▲ +31.1% |
| 2018 | -0.94x | $-92.20 Million | $-92.56 Million | $97.61 Million | ▼ -118.7% |
| 2017 | -0.43x | $-40.81 Million | $-41.14 Million | $94.49 Million | ▲ +20.8% |
| 2016 | -0.55x | $-48.16 Million | $-53.44 Million | $88.27 Million | ▼ -424.4% |
| 2015 | -0.10x | $-7.99 Million | $-13.12 Million | $76.83 Million | ▲ +83.4% |
| 2014 | -0.63x | $-38.45 Million | $-38.55 Million | $61.24 Million | ▼ -18.4% |
| 2013 | -0.53x | $-26.50 Million | $-26.53 Million | $49.99 Million | ▲ +17.7% |
| 2012 | -0.64x | $-37.28 Million | $-37.40 Million | $57.89 Million | ▼ -34.8% |
| 2011 | -0.48x | $-32.20 Million | $-32.25 Million | $67.40 Million | ▲ +25.6% |
| 2010 | -0.64x | $-28.23 Million | $-28.55 Million | $43.94 Million | ▼ -130.1% |
| 2009 | -0.28x | $-15.61 Million | $-16.22 Million | $55.92 Million | ▲ +45.7% |
| 2008 | -0.51x | $-19.66 Million | $-20.87 Million | $38.27 Million | ▼ -101.2% |
| 2007 | 42.65x | $3.32 Billion | $-25.00 Million | $77.81 Million | ▲ +14860.5% |
| 2006 | -0.29x | $-13.68 Million | $-15.21 Million | $47.33 Million | ▲ +48.4% |
| 2005 | -0.56x | $-22.85 Million | $-23.35 Million | $40.81 Million | ▲ +90.2% |
| 2004 | -5.70x | $-17.88 Million | $-18.15 Million | $3.13 Million | ▲ +15.6% |
| 2003 | -6.76x | $-11.14 Million | $-11.20 Million | $1.65 Million | ▲ +50.3% |
| 2002 | -13.61x | $-15.96 Million | $-16.36 Million | $1.17 Million | ▼ -311.2% |
| 2001 | -3.31x | $-7.55 Million | $-10.16 Million | $2.28 Million | ▼ -6707.2% |
| 2000 | -0.05x | $-454.34K | $-3.18 Million | $9.35 Million | ▲ +97.5% |
| 1999 | -1.95x | $-3.90 Million | $-4.90 Million | $2.00 Million | ▲ +28.2% |
| 1998 | -2.71x | $-3.80 Million | $-4.20 Million | $1.40 Million | ▲ +64.6% |
| 1997 | -7.67x | $-9.20 Million | $-10.30 Million | $1.20 Million | ▼ -100.5% |
| 1996 | -3.82x | $-6.50 Million | $-6.80 Million | $1.70 Million | ▲ +8.2% |
| 1995 | -4.17x | $-7.50 Million | $-7.70 Million | $1.80 Million | ▼ -9.3% |
| 1994 | -3.81x | $-6.10 Million | $-6.50 Million | $1.60 Million | — |